作者: J. Zidan , N. Haim , A. Beny , M. Stein , E. Gez
关键词:
摘要: Summary Background: Chemotherapy-induced diarrhea (CID) is a common side effect of number chemotherapeu tic agents. Conventional therapy for severe CID with opioids or loperamide moderately effective. A prospective trial was conducted using octreotide acetate treatment refractory to loperamide. Patients and methods: Thirty-two patients grade 2 3 were treated at dosage 100 ug subcutaneousl y 3x/day three days followed by 50 days. Previous chemotherapy consisted regimens containing fluorouracil, leucovorin, CPT-11, cyclophosphamide, methotrexate cisplatin. Primary tumors colorectal (n = 23), gastric 3), other cancers 6). Results: Complete resolution obtained in 30 32 (94%); 5 within 24 hours, 14 48 11 72 hours treatment. Nineteen as outpatients. Thirteen hospitalized median Response unaffected age, gender, performance status, previous primary tumor site. No effects related observed. Conclusions: Octreotide an effective, safe given primarily second-line after failure.